A randomized two-arm phase III study to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) versus CAPOX alone in post radical resection of patients with liver metastases of colorectal cancer

Autor:	R.A.E.M. Tollenaar, Otilia Dalesio, Sander B. Schouten, J R M van der Sijp, I. H. M. Borel Rinkes, Olaf Loosveld, T.M. van Gulik, A. Rijken, J. M. Smit, A.M. Bergman, R. van Hillegersberg, Emile E. Voest, Nikol Snoeren, M. Tol, Henk M.W. Verheul, E. J. Hesselink, Epie Boven, E. D. van Werkhoven, Annemieke Cats
Rok vydání:	2011
Předmět:	Oncology Cancer Research Chemotherapy medicine.medical_specialty Bevacizumab business.industry Colorectal cancer medicine.medical_treatment medicine.disease Resection Surgery Oxaliplatin Capecitabine Internal medicine medicine Radical resection business neoplasms medicine.drug
Zdroj:	Journal of Clinical Oncology. 29:3565-3565
ISSN:	1527-7755 0732-183X
Popis:	3565 Background: This study aimed to improve disease-free survival (DFS) for patients after radical resection of CRC liver metastases by adding bevacizumab to post resection chemotherapy with CAPOX...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f9c91ac6704e2fc780410831689b1915 https://doi.org/10.1200/jco.2011.29.15_suppl.3565 Zobrazit plný text záznamu